Understanding Wegovy Injections: How Much Are They and What You Need to Know

Last reviewed: June 21, 2026

Last updated: June 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that reduces appetite by signaling fullness to your brain and slowing gastric emptying. Originally developed for type 2 diabetes, semaglutide has demonstrated sustained weight loss of 15–22% in clinical trials when combined with lifestyle modifications. PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies, making precision weight loss accessible without insurance or membership fees.

How Semaglutide Injections Work for Weight Loss

Semaglutide activates GLP-1 receptors in your brain's hypothalamus, the region responsible for appetite regulation and satiety signals. This mechanism creates a prolonged feeling of fullness, reducing overall calorie intake without requiring willpower alone. The medication also slows the movement of food through your stomach, which extends the period of satisfaction after eating.

Weekly subcutaneous injections allow semaglutide to reach steady-state levels in your bloodstream, providing consistent appetite suppression throughout the week. Most patients self-administer injections at home using a small pen device, similar to insulin delivery. Clinical evidence shows that consistent dosing produces more reliable weight loss outcomes than sporadic administration.

Semaglutide Injection Pricing and Payment Options

PlexusDx compounded semaglutide injections start at $149 per month across flexible commitment tiers, with no flat per-compound pricing increases as your therapy progresses. Your dose may need to go up. Your price won't. This flat-rate model removes financial barriers to reaching therapeutic doses that work for your individual metabolism.

All PlexusDx medications are HSA and FSA eligible, allowing you to use pre-tax healthcare savings accounts to reduce out-of-pocket costs. PlexusDx serves all 50 states, requires no insurance verification, and charges no membership fees. Treatment begins after an initial consultation with a licensed clinician who reviews your medical history and confirms suitability for GLP-1 therapy.

Comparing Brand-Name vs. Compounded Semaglutide

Brand-name semaglutide (Ozempic, Wegovy) typically costs $900–$1,300 per month through traditional insurance or cash pay, with most plans requiring prior authorization and step therapy. Compounded semaglutide from licensed 503A pharmacies meets the same United States Pharmacopeia (USP) standards for purity, potency, and sterility, but at substantially lower cost due to reduced marketing and distribution expenses.

Compounded medications are not FDA-approved as finished products, but they are manufactured under state pharmacy board oversight and federal compounding regulations. PlexusDx sources all compounded semaglutide from licensed 503A compounding pharmacies that maintain rigorous quality assurance protocols. Patients report equivalent efficacy and tolerability between compounded and brand-name formulations in real-world use.

Side Effects, Safety, and Genetic Personalization

Common side effects of semaglutide include nausea, constipation, and mild vomiting, especially during dose escalation phases. These effects typically diminish within 1–2 weeks as your body adapts. Serious adverse events are rare but include pancreatitis, gallbladder issues, and thyroid concerns; patients with personal or family history of medullary thyroid cancer should not use GLP-1 agonists.

PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month) to identify your unique genetic predispositions across 14 metabolic pathways and 150+ insights. This test examines key variants in GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) to help predict your individual response to semaglutide and optimize your treatment plan. Genetic insights enable more personalized dosing strategies and help identify patients most likely to achieve sustained weight loss.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much does semaglutide injection cost compared to Wegovy?

PlexusDx compounded semaglutide starts at $149 per month, while brand-name Wegovy typically costs $900–$1,300 monthly. Both deliver the same active ingredient; compounded versions cost less due to lower distribution and marketing overhead. Your dose may need to go up. Your price won't.

How does semaglutide actually help you lose weight?

Semaglutide mimics the GLP-1 hormone, which signals your brain that you're full and slows stomach emptying. This reduces hunger cues and calorie intake without requiring constant dieting. Clinical trials show patients lose 15–22% of body weight over 68 weeks when combining semaglutide with modest lifestyle changes.

Do I need insurance to get semaglutide through PlexusDx?

No. PlexusDx serves all 50 states without requiring insurance, and all compounded medications are HSA and FSA eligible. You can pay directly with pre-tax healthcare savings accounts or out-of-pocket at the flat monthly rate.

What are the most common side effects of semaglutide injections?

Nausea, constipation, and mild vomiting are most frequent, especially during dose increases, but typically resolve within 1–2 weeks. Serious side effects are rare but include pancreatitis and gallbladder disease. Discuss your full medical history with your PlexusDx clinician before starting therapy.

How can genetic testing improve my semaglutide results?

PlexusDx Precision Peptide Genetic Test identifies your variants in GLP1R, GIPR, FTO, and MC4R genes, which influence how effectively your body responds to semaglutide. These insights help optimize your dose and predict long-term success, making treatment more personalized and efficient. The test costs $99 as an add-on after your first month.

Related Reading

• What Genetic Factors Determine How Much Sleep You Need Each Night
• Genetic Testing 101 What You Need To Know Before Getting Tested
• Wegovy Weight Loss Injections
• Does My Dna Affect How Much Sleep I Need For Mental Clarity

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.